Clinical trial (b)(6).It was reported that in-stent thrombosis occurred.The subject was enrolled in the (b)(6) clinical study on (b)(6) 2018 and the index procedure was performed on the same day.The target lesion was 70% stenosis located in the right distal superficial femoral artery (sfa), 60 mm long with a proximal reference vessel diameter of 8 mm and distal reference vessel diameter of 6 mm and was classified as a tasc ii a lesion.The target lesion was treated with direct placement of a 6 mm x 60 mm eluvia drug-eluting vascular stent system.Following post-dilation, residual stenosis was 18%.The subject was discharged with antiplatelet therapy the next day.On (b)(6) 2021, 980 days post-index procedure, the subject presented due to recently worsening lower limb pain without trophic disorder and a complete thrombosis noted in the right sfa stent.Doppler ultrasound examination of the lower extremity arterial system revealed the stent completely thrombosed with a resumption of patency in the region of the proximal popliteal artery with subsequent demodulated and dampened flow in the three arteries of the leg, which were still perfectly patent.The common femoral artery was nicely patent, however, a large posterior calcified plaque, without anything to suggest significant stenosis.
|